ArticleEuropean journal of medical research2025
Low-level red light inhibits human retinal pigment epithelial cell fibrosis via UBE2C in a myopia-simulating hypoxic microenvironment.
Article in European journal of medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Baicalin Protects ARPE-19 Cells Against BRVO-Related Hypoxic Injury by Preserving Mitochondrial Function and Inhibiting Ferroptosis.Antioxidants (Basel, Switzerland) · 2026Article
- Ocular Transmission of Red and Violet Light: Insights into Light-Based Myopia Therapies.Translational vision science & technology · 2026Article
- Significant Improvement in High Myopic Anisometropic Amblyopia Treated With Repeated Low-Level Red-Light (RLRL) Therapy: A Case Report.The American journal of case reports · 2026Article
- Clinical efficacy and cost-effectiveness of four myopia control interventions in children: a single-center retrospective study.Scientific reports · 2026Observational
- Myopia development: multifactorial interplay, molecular mechanisms and possible strategies.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundLow-level red light (LLRL) irradiation may inhibit myopia occurrence and progression. Understanding how LLRL inhibits fibrosis in human retinal pigment epithelial (hRPE) cells is critical to inhibiting myopia progression and developing novel therapeutic strategies. Here, we explored the effects of LLRL on hRPE cells in a myopia-simulating hypoxic microenvironment and elucidated the mechanisms through which it inhibits scleral remodeling.
methodsWe first used the MTT assay to analyze hRPE cell proliferation under hypoxic conditions after LLRL irradiation at varying frequencies over different durations. RNA sequencing was used to screen for key signaling molecules leading to hRPE cell fibrosis. Western blotting, reverse transcription quantitative polymerase chain reaction, and immunofluorescence assay were used to detect the role of ubiquitin binding enzyme E2 C (UBE2C) in hRPE cell fibrosis under LLRL irradiation.
resultsLLRL was noted to regulate the extracellular matrix, inhibiting fibrosis in hypoxic hRPE cells. Moreover, supernatant of LLRL-treated hypoxic hRPE cells inhibited scleral remodeling in human scleral fibroblasts. Mechanistically, LLRL inhibited cell fibrosis by regulating UBE2C activation of the AKT/mTOR pathway.
conclusionIn a hypoxic environment, LLRL irradiation can prevent fibroblast transformation in hRPE cells, indicating its potential in scleral remodeling inhibition. Our results revealed the molecular mechanism through which red light controls myopia and provide evidence for further basic and clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.